$147.35
+2.69
(+1.86%)▲
2.85%
Downside
Day's Volatility :3.0%
Upside
0.15%
29.3%
Downside
52 Weeks Volatility :34.25%
Upside
7.01%
Period | Ensign Group Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 0.67% | -6.9% | 0.0% |
6 Months | 23.69% | -1.7% | 0.0% |
1 Year | 35.77% | 10.4% | 0.0% |
3 Years | 79.35% | 8.8% | -24.1% |
Market Capitalization | 8.4B |
Book Value | $30.71 |
Dividend Share | 0.24 |
Dividend Yield | 0.17% |
Earnings Per Share (EPS) | 4.12 |
PE Ratio | 35.76 |
PEG Ratio | 1.57 |
Wall Street Target Price | 169.5 |
Profit Margin | 5.84% |
Operating Margin TTM | 8.26% |
Return On Assets TTM | 4.02% |
Return On Equity TTM | 14.96% |
Revenue TTM | 4.1B |
Revenue Per Share TTM | 72.8 |
Quarterly Revenue Growth YOY | 15.0% |
Gross Profit TTM | 534.9M |
EBITDA | 360.0M |
Diluted Eps TTM | 4.12 |
Quarterly Earnings Growth YOY | 0.21 |
EPS Estimate Current Year | 5.49 |
EPS Estimate Next Year | 6.15 |
EPS Estimate Current Quarter | 1.38 |
EPS Estimate Next Quarter | 1.46 |
What analysts predicted
Upside of 15.03%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.1B | ↑ 12.12% |
Net Income | 92.4M | ↑ 128.2% |
Net Profit Margin | 4.45% | ↑ 2.26% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↓ 1.78% |
Net Income | 110.5M | ↑ 19.67% |
Net Profit Margin | 5.43% | ↑ 0.98% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↑ 17.98% |
Net Income | 170.5M | ↑ 54.23% |
Net Profit Margin | 7.1% | ↑ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↑ 9.36% |
Net Income | 194.7M | ↑ 14.18% |
Net Profit Margin | 7.41% | ↑ 0.31% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↑ 15.15% |
Net Income | 224.7M | ↑ 15.43% |
Net Profit Margin | 7.43% | ↑ 0.02% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.7B | ↑ 23.27% |
Net Income | 209.4M | ↓ 6.8% |
Net Profit Margin | 5.61% | ↓ 1.82% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 921.3M | ↑ 3.89% |
Net Income | 64.0M | ↑ 6.92% |
Net Profit Margin | 6.95% | ↑ 0.2% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 940.8M | ↑ 2.11% |
Net Income | 63.9M | ↓ 0.2% |
Net Profit Margin | 6.79% | ↓ 0.16% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 980.4M | ↑ 4.21% |
Net Income | 21.7M | ↓ 66.04% |
Net Profit Margin | 2.21% | ↓ 4.58% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 982.9M | ↑ 0.26% |
Net Income | 68.8M | ↑ 217.34% |
Net Profit Margin | 7.0% | ↑ 4.79% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.0B | ↑ 5.43% |
Net Income | 71.0M | ↑ 3.16% |
Net Profit Margin | 6.85% | ↓ 0.15% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.1B | ↑ 4.39% |
Net Income | 78.4M | ↑ 10.47% |
Net Profit Margin | 7.25% | ↑ 0.4% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 7.21% |
Total Liabilities | 579.6M | ↓ 3.78% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 99.83% |
Total Liabilities | 1.7B | ↑ 194.29% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↑ 7.78% |
Total Liabilities | 1.7B | ↑ 1.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 11.98% |
Total Liabilities | 1.8B | ↑ 5.88% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 3.5B | ↑ 21.1% |
Total Liabilities | 2.2B | ↑ 20.47% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 4.2B | ↑ 21.02% |
Total Liabilities | 2.7B | ↑ 21.65% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.0B | ↑ 2.33% |
Total Liabilities | 2.6B | ↑ 0.65% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.1B | ↑ 3.28% |
Total Liabilities | 2.6B | ↑ 2.25% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.2B | ↑ 2.34% |
Total Liabilities | 2.7B | ↑ 2.43% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.3B | ↑ 3.13% |
Total Liabilities | 2.7B | ↑ 1.67% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.4B | ↑ 2.99% |
Total Liabilities | 2.8B | ↑ 1.81% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.6B | ↑ 4.32% |
Total Liabilities | 2.9B | ↑ 3.75% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 210.3M | ↑ 188.27% |
Investing Cash Flow | -151.2M | ↑ 41.86% |
Financing Cash Flow | -70.3M | ↓ 484.99% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 168.9M | ↓ 19.67% |
Investing Cash Flow | -247.0M | ↑ 63.36% |
Financing Cash Flow | 83.3M | ↓ 218.39% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 373.4M | ↑ 121.01% |
Investing Cash Flow | -58.7M | ↓ 76.25% |
Financing Cash Flow | -137.3M | ↓ 264.87% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 275.7M | ↓ 26.16% |
Investing Cash Flow | -173.9M | ↑ 196.44% |
Financing Cash Flow | -76.1M | ↓ 44.55% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 272.5M | ↓ 1.15% |
Investing Cash Flow | -186.2M | ↑ 7.06% |
Financing Cash Flow | -32.3M | ↓ 57.63% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 119.7M | ↑ 147.68% |
Investing Cash Flow | -26.5M | ↓ 26.43% |
Financing Cash Flow | -269.0K | ↓ 83.93% |
Sell
Neutral
Buy
Ensign Group Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ensign Group Inc | -0.97% | 23.69% | 35.77% | 79.35% | 239.99% |
Fresenius Medical Care Ag | 5.22% | 5.42% | 11.35% | -29.42% | -40.21% |
Hca Holdings, Inc. | -18.6% | 4.34% | 31.31% | 38.19% | 138.68% |
Tenet Healthcare Corp. | -5.93% | 13.42% | 118.4% | 88.34% | 370.63% |
Universal Health Services Inc. | -15.02% | 10.46% | 42.8% | 55.32% | 41.84% |
Davita Healthcare Partners Inc. | 0.6% | 21.81% | 65.0% | 59.87% | 126.46% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ensign Group Inc | 35.76 | 35.76 | 1.57 | 5.49 | 0.15 | 0.04 | 0.0 | 30.71 |
Fresenius Medical Care Ag | 18.31 | 18.31 | 0.44 | 2.23 | 0.06 | 0.03 | 0.03 | 46.43 |
Hca Holdings, Inc. | 14.95 | 14.95 | 1.07 | 21.97 | 0.12 | 0.12 | 0.01 | -8.57 |
Tenet Healthcare Corp. | 4.69 | 4.69 | 0.7 | 11.2 | 0.6 | 0.07 | NA | 40.32 |
Universal Health Services Inc. | 13.17 | 13.17 | 1.87 | 15.95 | 0.16 | 0.07 | 0.0 | 100.14 |
Davita Healthcare Partners Inc. | 17.39 | 17.39 | 1.22 | 9.74 | 0.45 | 0.07 | NA | 4.68 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ensign Group Inc | Buy | $8.4B | 239.99% | 35.76 | 5.84% |
Fresenius Medical Care Ag | Hold | $13.0B | -40.21% | 18.31 | 3.43% |
Hca Holdings, Inc. | Buy | $84.3B | 138.68% | 14.95 | 8.52% |
Tenet Healthcare Corp. | Buy | $14.1B | 370.63% | 4.69 | 14.91% |
Universal Health Services Inc. | Hold | $13.0B | 41.84% | 13.17 | 6.66% |
Davita Healthcare Partners Inc. | Hold | $13.2B | 126.46% | 17.39 | 6.53% |
Insights on Ensign Group Inc
Revenue is up for the last 15 quarters, 627.25M → 1.08B (in $), with an average increase of 3.8% per quarter
Netprofit is up for the last 4 quarters, 21.69M → 78.44M (in $), with an average increase of 27.0% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 118.4% return, outperforming this stock by 82.6%
In the last 3 years, Tenet Healthcare Corp. has given 88.3% return, outperforming this stock by 9.0%
BlackRock Inc
Vanguard Group Inc
Wasatch Advisors LP
Capital Research Global Investors
State Street Corp
FMR Inc
In the quarter ending March,2024. Ensign Group Inc has declared dividend of $0.06
Read Moreskilled nursing/assisted living
Organization | Ensign Group Inc |
Employees | 35300 |
CEO | Mr. Christopher R. Christensen |
Industry | Health Services |
Cleanspark Inc
$147.35
+1.86%
Vaneck Vectors Fallen Angel Hiyld Bd Etf
$147.35
+1.86%
Borgwarner Inc.
$147.35
+1.86%
Central Garden & Pet Co A Shares
$147.35
+1.86%
Esab Corp
$147.35
+1.86%
Sasol Ltd.
$147.35
+1.86%
Ishares Msci Eafe Min Vol Factor Etf
$147.35
+1.86%
Vanguard Ultra Short Bond Et
$147.35
+1.86%
Hutchison China Meditech Limited
$147.35
+1.86%